The primary efficacy endpoint was transform from baseline MADRS score. This quick-phrase research discovered that, in comparison to intranasal placebo additionally oral antidepressant, intranasal esketamine along side an oral antidepressant substantially enhanced depressive signs and symptoms right after 4 months by a indicate distinction of 4 fact